Clinical Significance of FLT3‐ITD Variation Allele Frequency in Acute Myeloid Leukemia: A Multicenter Study
Hematological Oncology · 2026
DOI: 10.1002/hon.70218 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Hematological Oncology, 2026. Verfasst von Laibing Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Third Affiliated Hospital of Soochow University (The First People's Hospital of Changzhou), Changzhou, China. Hauptthemen laut MEDLINE: fms-Like Tyrosine Kinase 3, Leukemia, Myeloid, Acute, Gene Frequency, Mutation. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Key project of Jiangsu Province Health Committee, Changzhou Medical Center, Nanjing Medical University.
Abstract (Originalsprache)
The specific prognostic impact of FLT3‐ITD variant allele frequency (VAF) in acute myeloid leukemia (AML) remains unclear. In this multi‐center study of 190 AML patients harboring FLT3‐ITD mutations, a VAF cut‐off of 40% was applied. Patients with high VAF (≥ 40%) exhibited significantly higher white blood cell counts, lactate dehydrogenase levels, and bone marrow blast percentages, alongside markedly shorter median overall survival (OS). Although high VAF was independently associated with inferior outcomes in the overall multivariate Cox regression analysis, its effect was profoundly amplified in the presence of co‐mutations in NPM1 or DNMT3A . This suggests that high VAF may function not as an absolute, independent determinant, but primarily as a potent “risk amplifier.” Notably, allogeneic hematopoietic stem cell transplantation (allo‐HSCT) effectively mitigated this survival disadvantage. Furthermore, we characterized a non‐linear relationship between VAF and mortality risk, with a sharp increase observed once the VAF burden exceeded 34%. In conclusion, a quantitative VAF ≥ 40% should be considered a context‐dependent prognostic marker for risk stratification. Allo‐HSCT represents a critical intervention capable of overcoming the exceedingly poor prognosis associated with high VAF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The Third Affiliated Hospital of Soochow University (The First People's Hospital of Changzhou), Changzhou, China.
- Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Hematology, Yancheng First People's Hospital, Yancheng, China.
ORCID-Profile: Laibing Guo, Lijun Wen, Weiying Gu
Förderung
- Key project of Jiangsu Province Health Committee
- Changzhou Medical Center, Nanjing Medical University
Zitieren
APA
Guo, L., Song, J., Zang, H., Cao, Y., Lin, Y., Zheng, Z., Chen, S., Wen, L., Miao, Y., & Gu, W. (2026). Clinical Significance of FLT3‐ITD Variation Allele Frequency in Acute Myeloid Leukemia: A Multicenter Study. Hematological Oncology. https://doi.org/10.1002/hon.70218
Vancouver
Guo L, Song J, Zang H, Cao Y, Lin Y, Zheng Z, et al. Clinical Significance of FLT3‐ITD Variation Allele Frequency in Acute Myeloid Leukemia: A Multicenter Study. Hematological Oncology. 2026. doi:10.1002/hon.70218
BibTeX
@article{Guo2026,
author = {Guo, Laibing and Song, Jingyan and Zang, Haoyu and Cao, Yang and Lin, Yan and Zheng, Zhuojun and Chen, Suning and Wen, Lijun and Miao, Yuqing and Gu, Weiying},
title = {Clinical Significance of FLT3‐ITD Variation Allele Frequency in Acute Myeloid Leukemia: A Multicenter Study},
journal = {Hematological Oncology},
year = {2026},
doi = {10.1002/hon.70218}
}
EUVIMED